Literature DB >> 8149732

Clinical evaluation of 14 patients with the Charles Bonnet syndrome (isolated visual hallucinations).

R J Teunisse1, F G Zitman, D C Raes.   

Abstract

A group of 14 patients with isolated visual hallucinations who met the criteria proposed by Gold and Rabins for Charles Bonnet syndrome (with the exception of the criterion "hallucinations are stereotyped") underwent psychiatric, neurologic, and ophthalmologic tests. Additional common characteristics of the hallucinations included the absence of personal meaning of the content of the hallucinations and the disappearance of the hallucinations when the patients closed their eyes. There was no evidence for a relationship of the syndrome to psychiatric disorders. In the majority of cases, ocular pathology and neurologic disturbances were diagnosed. There was also evidence that most patients were suffering from social isolation. From these data it is concluded that a combination of factors is probably responsible for the Charles Bonnet syndrome.

Entities:  

Mesh:

Year:  1994        PMID: 8149732     DOI: 10.1016/0010-440x(94)90172-4

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

1.  Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops.

Authors:  R L Tomsak; C R Zaret; D Weidenthal
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

Review 2.  The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria.

Authors:  Ali G Hamedani; Victoria S Pelak
Journal:  Curr Treat Options Neurol       Date:  2019-07-25       Impact factor: 3.598

3.  Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre.

Authors:  C S H Tan; V S Y Lim; D Y M Ho; E Yeo; B Y Ng; K G Au Eong
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 4.  Light, sleep-wake rhythm, and behavioural and psychological symptoms of dementia in care home patients: Revisiting the sundowning syndrome.

Authors:  Ta-Wei Guu; Dag Aarsland; Dominic Ffytche
Journal:  Int J Geriatr Psychiatry       Date:  2022-05       Impact factor: 3.850

5.  Negative outcome Charles Bonnet syndrome.

Authors:  Thomas M Cox; Dominic H ffytche
Journal:  Br J Ophthalmol       Date:  2014-05-13       Impact factor: 4.638

Review 6.  Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome.

Authors:  Linda Pang
Journal:  Optom Vis Sci       Date:  2016-12       Impact factor: 1.973

Review 7.  Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Authors:  Raquel N Taddei; Seyda Cankaya; Sandeep Dhaliwal; K Ray Chaudhuri
Journal:  Parkinsons Dis       Date:  2017-09-12

8.  Exacerbation of visual hallucinations in Charles Bonnet syndrome due to the social implications of COVID-19.

Authors:  Lee Jones; Lara Ditzel-Finn; Judith Potts; Mariya Moosajee
Journal:  BMJ Open Ophthalmol       Date:  2021-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.